Skip to main content
OpenTrials
Completed

NCT Number: NCT02035943

Tight Glycemic Control and Insulin Administration During Parenteral Nutrition

In this study the investigators want to comare safety and efficacy of two different metods to administrate insulin during parenteral nutrition.

Completed

Looking for future studies?

Notify Me

Key information

Age range

16 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Policlinico Hospital

Milan, MI, 20122, Italy

About this study

In this study the investigators want to compare safety and efficacy of two different metods to administrate insulin during parenteral nutrition.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Critical ill patients undergone parenteral nutrition

Exclusion criteria

  • Acute cerebral injury, pregnancy

Treatment and study plan

Insulin separated

Dietary Supplement

separate continuos infusion of insulin

Insulin added to parenteral nutrition

Dietary Supplement

Insulin added to parenteral nutrition

Primary outcomes

  1. Number of glucose level control out of range (80-110 mg/dl)

    Time frame: ICU stay (a week on average)

Sponsors and collaborators

Lead sponsor

Policlinico Hospital

Other

Registry information

Official study title

Tight Glycemic Control and Insulin Administration During Parenteral Nutrition, in Critical Ill Patients

Important dates

Study start
2008
Primary completion
2008
Study completion
2008
First posted
Jan 14, 2014
Registry last updated
Jan 14, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.